Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts. [electronic resource]
Producer: 20200803Description: 1975 p. digitalISSN:- 2041-1723
- Aged
- Animals
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents -- pharmacology
- Biopsy
- Camptothecin -- analogs & derivatives
- Carcinoma, Transitional Cell -- genetics
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Genetic Variation
- High-Throughput Nucleotide Sequencing
- Humans
- Immunoconjugates -- pharmacology
- Interleukin Receptor Common gamma Subunit -- genetics
- Male
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Middle Aged
- Mutation
- Neoplasm Metastasis
- Neoplasm Transplantation
- Phenotype
- Precision Medicine
- Prospective Studies
- Quinolines -- pharmacology
- Retrospective Studies
- Sequence Analysis, RNA
- Trastuzumab
- Urinary Bladder Neoplasms -- genetics
- Urothelium -- pathology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.